Mar 24, 2021 / 09:00PM GMT
Operator
Greetings. Welcome to the Navidea Biopharmaceuticals Q4 2020 Earnings Call. (Operator Instructions) Please note, this conference is being recorded.
I will now turn the conference over to your host, Jed Latkin, CEO of Navidea. Thank you. You may begin.
Jed A. Latkin - Navidea Biopharmaceuticals, Inc. - CEO, COO, CFO & Director
Thank you, Hilary. First off, I want to start by saying this call is being webcast live on our website and a replay will be made available. Following prepared remarks, we will be conducting a question-and-answer segment. Navidea's Chief Medical Officer, Dr. Rosol; and the company's Chief Business Officer, Joel Kaufman, will be joining me on the call today as well.
During the course of this conference call, we will be making forward-looking statements regarding future events and the future performance of the company. These events relate to our business plans to develop Navidea's molecular diagnostics and immunotherapeutics, which include clinical and regulatory developments and timing of clinical data readouts along
Q4 2020 Navidea Biopharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot